<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Epstein-Barr virus (EBV) major latent promoter C drives the expression of <z:mp ids='MP_0001799'>viral</z:mp> nuclear proteins important in lymphocyte immortalization and as targets for immune surveillance by cytotoxic T cells </plain></SENT>
<SENT sid="1" pm="."><plain>Hypermethylation of the C promoter silences its transcription </plain></SENT>
<SENT sid="2" pm="."><plain>This promoter is methylated and silent in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, and nasal <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>However, it is never methylated in the EBV-immortalized lymphoblastoid cell lines that serve as a model for EBV-associated <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We have analyzed C promoter methylation in iatrogenic EBV-associated B-cell <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e>, mainly posttransplant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, using a sensitive polymerase chain reaction-based C promoter methylation assay </plain></SENT>
<SENT sid="5" pm="."><plain>Our results showed <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> with methylation of <z:mp ids='MP_0001799'>viral</z:mp> DNA in specimens from 3 of 13 patients </plain></SENT>
<SENT sid="6" pm="."><plain>In specimens from two of these patients, only methylated <z:mp ids='MP_0001799'>viral</z:mp> DNA was detected and <z:mp ids='MP_0001799'>viral</z:mp> nuclear antigen expression was correspondingly restricted </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001425'>Heterogeneity</z:hpo> in C promoter methylation and expression of associated transcripts may be an important determinant of the growth properties of lymphoproliferative lesions and may provide an explanation for the failure of some <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> to respond to withdrawal or reduction of immunosuppressive therapy </plain></SENT>
</text></document>